Implantation of a sulcus multifocal intraocular lens: long-term outcomes

Session Details

Session Title: Pseudophakic IOLs: Toric, Multifocal, Accommodative

Session Date/Time: Monday 09/10/2017 | 14:30-16:00

Paper Time: 15:22

Venue: Room 4.1

First Author: : M.Cassagne FRANCE

Co Author(s): :    M. Porterie   L. Gauthier   P. Fournie   F. Malecaze           

Abstract Details

Purpose:

To evaluate the visual performance and tolerance of the combined implantation of a monofocal IOL in the capsular bag and a new generation of multifocal IOL in the ciliary sulcus.

Setting:

This multicentric study was conducted in the ophthalmology department of the University Hospital Center of Toulouse (France) and in the Helios Clinic in Saint Jean de Luz (France) between May 2012 and January 2014.

Methods:

This prospective study included 54 eyes of 31 patients (20 women and 11 men) implanted with the Reverso IOL (Cristalens, France) in the ciliary sulcus. 47 eyes were having cataract surgery, 7 eyes benefited from a secondary implantation to satisfy their request to be free from any spectacle. Uncorrected and best corrected visual acuity, IOL centration and position, pupil status, patient satisfaction and UBM echography were investigated for 18 months.

Results:

Uncorrected distance monocular visual acuity was 0.13+/-0.18 logMAR. Binocular distance acuity improved to 0.03+/-0.06 and binocular near visual acuity 0.12+/-0.08 LogMAR. In one eye, after a facial trauma in the first postoperative week, one IOL needed repositionning. Pupil anatomy was unremarkable; in one eye slight correctopia was noticed. IOP remained stable in all eyes. Patient satisfaction was high (89% of good to excellent vision). UBM echography at 18 months showed a stable position of IOL but an annular fibrosis of the anterior capsular bag.

Conclusions:

The implant of a multifocal IOL designed for the ciliary sulcus at the time or after cataract surgery was safe and effective in this study. It provided the same results as primary multifocal implantation, with the advantage of reversibility and the potential to be employed in eyes already pseudophakic. Longer follow-up and largest cohort are needed to confirm these results.

Financial Disclosure:

NONE